Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Jan;31(1):95–101. doi: 10.1128/iai.31.1.95-101.1981

Absence of Correlation Between Delayed-Type Hypersensitivity and Protection in Experimental Systemic Candidiasis in Immunized Mice

Bruno Hurtrel 1, Philippe H Lagrange 1, Jean-Claude Michel 1
PMCID: PMC351756  PMID: 7012009

Abstract

We found that in mice which had been immunized intraperitoneally with 2 × 108 heat-killed Candida albicans cells there was a striking temporal relationship between resistance to systemic challenge with 106 living C. albicans cells and a number of measurable cellular parameters of the host response. These included the emergence of delayed-type hypersensitivity and the development of granulocytosis. Since it had been shown in previous work that granulocytosis was associated with an increase in resistance when nonspecific immunostimulation was used, we performed experiments to induce delayed-type hypersensitivity without any measurable modification of the granulocyte population. Adoptive transfer of delayed-type hypersensitivity with spleen cells from immune and resistant donor mice did not produce any increase in resistance in normal recipients. When separate groups of mice were immunized intraperitoneally or subcutaneously with varying doses of heat-killed C. albicans, we found that doses of less than 108 cells did induce significant delayed-type hypersensitivity without any increase in granulocytosis. In such mice, as well as in animals pretreated with immunomodulators before immunization with heat-killed C. albicans, the presence of cell-mediated immunity, as measured by the delayed-type hypersensitivity test, was not associated with an increase in resistance against systemic candidiasis. On the contrary, the results suggested that cell-mediated immunity was associated with an increase in the susceptibility of these mice. The same effect on candidiasis susceptibility was observed when animals were immunized with heat-killed filamentous C. albicans.

Full text

PDF
95

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander J., Curtis J. Development of delayed hypersensitivity responses in Mycobacterium lepraemurium infections in resistant and susceptible strains of mice. Immunology. 1979 Mar;36(3):563–567. [PMC free article] [PubMed] [Google Scholar]
  2. Clark C., Azar M. M. Comparison of murine delayed hypersensitivity reactions elicited with particle-associated versus soluble human gamma-globulin. Int Arch Allergy Appl Immunol. 1977;54(2):143–150. doi: 10.1159/000231817. [DOI] [PubMed] [Google Scholar]
  3. Cutler J. E. Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. J Reticuloendothel Soc. 1976 Feb;19(2):121–124. [PubMed] [Google Scholar]
  4. Evans E. G., Odds F. C., Richardson M. D., Holland K. T. Optimum conditions for initiation of filamentation in Candida albicans. Can J Microbiol. 1975 Mar;21(3):338–342. doi: 10.1139/m75-048. [DOI] [PubMed] [Google Scholar]
  5. Floc'h F. E., Biguet J., Andrieu S., Vernes A. Etude cinétique de l'hypersensibilité de type retardé dans la candidose expérimentale de la souris. Mycopathol Mycol Appl. 1974 Dec 18;54(4):475–483. doi: 10.1007/BF02050053. [DOI] [PubMed] [Google Scholar]
  6. Giger D. K., Domer J. E., McQuitty J. T., Jr Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans. Infect Immun. 1978 Feb;19(2):499–509. doi: 10.1128/iai.19.2.499-509.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Giger D. K., Domer J. E., Moser S. A., McQuitty J. T., Jr Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted mice. Infect Immun. 1978 Sep;21(3):729–737. doi: 10.1128/iai.21.3.729-737.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goodman J. W., Basford N. L., Shinpock S. G. On the role of thymus in hemopoietic differentiation. Blood Cells. 1978;4(1-2):53–64. [PubMed] [Google Scholar]
  9. Hurtrel B., Lagrange P. H., Michel J. C. Systemic candidiasis in mice. I.--Correlation between kidney infection and mortality rate. Ann Immunol (Paris) 1980 Jan-Feb;131C(1):93–104. [PubMed] [Google Scholar]
  10. Hurtrel B., Lagrange P. H., Michel J. C. Systemic candidiasis in mice. II.--Main role of polymorphonuclear leukocytes in resistance to infection. Ann Immunol (Paris) 1980 Jan-Feb;131C(1):105–118. [PubMed] [Google Scholar]
  11. Hurtrel B., Lagrange P. H. Réactions d'hypersensibilité de type retardé induites par Candida albicans chez la souris. Ann Immunol (Paris) 1978 Jul-Sep;129 100(5):653–668. [PubMed] [Google Scholar]
  12. Kirkpatrick C. H., Chandler J. W., Schimke R. N. Chronic mucocutaneous moniliasis with impaired delayed hypersensitivity. Clin Exp Immunol. 1970 Mar;6(3):375–385. [PMC free article] [PubMed] [Google Scholar]
  13. Kirkpatrick C. H., Rich R. R., Bennett J. E. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med. 1971 Jun;74(6):955–978. doi: 10.7326/0003-4819-74-6-955. [DOI] [PubMed] [Google Scholar]
  14. Kirkpatrick C. H., Rich R. R., Smith T. K. Effect of transfer factor on lymphocyte function in anergic patients. J Clin Invest. 1972 Nov;51(11):2948–2958. doi: 10.1172/JCI107119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lagrange P. H., Hurtrel B. La réaction locale granulomateuse après injection sous-cutanée de BCG chez la souris. II.--Corrélations avec la réponse immune. Ann Immunol (Paris) 1978 Apr-Jun;129 100(4):547–558. [PubMed] [Google Scholar]
  16. Lagrange P. H., Mackaness G. B. A stable form of delayed-type hypersensitivity. J Exp Med. 1975 Jan 1;141(1):82–96. doi: 10.1084/jem.141.1.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lagrange P. H., Mackaness G. B., Miller T. E. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med. 1974 Jun 1;139(6):1529–1539. doi: 10.1084/jem.139.6.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lagrange P. H., Thickstun P. M. In vivo antitumor activity of various forms of delayed-type hypersensitivity in mice. J Natl Cancer Inst. 1979 Feb;62(2):429–436. [PubMed] [Google Scholar]
  19. Lehrer R. I., Cline M. J. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest. 1969 Aug;48(8):1478–1488. doi: 10.1172/JCI106114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Leijh P. C., van den Barselaar M. T., van Furth R. Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect Immun. 1977 Aug;17(2):313–318. doi: 10.1128/iai.17.2.313-318.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mackaness G. B., Lagrange P. H., Miller T. E., Ishibashi T. Feedback inhibition of specifically sensitized lymphocytes. J Exp Med. 1974 Mar 1;139(3):543–559. doi: 10.1084/jem.139.3.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Moser S. A., Domer J. E. Effects of cyclophosphamide on murine candidiasis. Infect Immun. 1980 Feb;27(2):376–386. doi: 10.1128/iai.27.2.376-386.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Moser S. A., Domer J. E., Mather F. J. Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge. Infect Immun. 1980 Jan;27(1):140–149. doi: 10.1128/iai.27.1.140-149.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mourad S., Friedman L. Passive immunization of mice against Candida albicans. Sabouraudia. 1968 Feb;6(2):103–105. [PubMed] [Google Scholar]
  25. Pearsall N. N., Adams B. L., Bunni R. Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. J Immunol. 1978 Apr;120(4):1176–1180. [PubMed] [Google Scholar]
  26. Poulter L. W., Lefford M. J. Development of delayed-type hypersensitivity during Mycobacterium lepraemurium infection in mice. Infect Immun. 1977 Aug;17(2):439–446. doi: 10.1128/iai.17.2.439-446.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Quie P. G., White J. G., Holmes B., Good R. A. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest. 1967 Apr;46(4):668–679. doi: 10.1172/JCI105568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rifkind D., Frey J. A. Influence of Androgen and Estrogen on Delayed Skin Test Reactivity to Candida albicans. Infect Immun. 1974 Nov;10(5):971–974. doi: 10.1128/iai.10.5.971-974.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rogers T. J., Balish E., Manning D. D. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J Reticuloendothel Soc. 1976 Oct;20(4):291–298. [PubMed] [Google Scholar]
  30. Rogers T. J., Balish E. The role of activated macrophages in resistance to experimental renal candidiasis. J Reticuloendothel Soc. 1977 Oct;22(4):309–318. [PubMed] [Google Scholar]
  31. Rogers T., Balish E. Experimental Candida albicans infection in conventional mice and germfree rats. Infect Immun. 1976 Jul;14(1):33–38. doi: 10.1128/iai.14.1.33-38.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ruthe R. C., Andersen B. R., Cunningham B. L., Epstein R. B. Efficacy of granulocyte transfusions in the control of systemic candidiasis in the leukopenic host. Blood. 1978 Sep;52(3):493–498. [PubMed] [Google Scholar]
  33. Salvin S. B., Nishio J., Shonnard J. T. Two new inhibitory activities in blood of mice with delayed hypersensitivity, after challenge with specific antigen. Infect Immun. 1974 Apr;9(4):631–635. doi: 10.1128/iai.9.4.631-635.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Valdimarsson H., Wood C. B., Hobbs J. R., Holt P. J. Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor. Clin Exp Immunol. 1972 Jun;11(2):151–163. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES